Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 May 10;17(5):1016-1018.
doi: 10.1016/j.stemcr.2022.03.015. Epub 2022 Apr 21.

Financial risks posed by unproven cell interventions: Estimation of refunds from medical expense deductions in Japan

Taichi Hatta  1 , Kazuki Ide  2 , Misao Fujita  3 , Tsunakuni Ikka  4
Affiliations
Comment

Financial risks posed by unproven cell interventions: Estimation of refunds from medical expense deductions in Japan

Taichi Hatta et al. Stem Cell Reports. .

Abstract

Master et al. (2021) declared that the unproven stem cell intervention (SCI) industry is a global health problem. We fully agree with this opinion but would like to point out that there are financial risks. In this letter, we estimate the total refund amount paid by the government for cell-based interventions offered under private practice in Japan.

PubMed Disclaimer

Comment on

References

    1. Berger I., Ahmad A., Bansal A., Kapoor T., Sipp D., Rasko J.E.J. Global distribution of businesses marketing stem cell-based interventions. Cell Stem Cell. 2016;19:158–162. doi: 10.1016/j.stem.2016.07.015. - DOI - PubMed
    1. Cyranoski D. The potent effects of Japan's stem-cell policies. Nature. 2019;573:482–485. doi: 10.1038/d41586-019-02847-3. - DOI - PubMed
    1. Fujita M., Hatta T., Ozeki R., Akabayashi A. The current status of clinics providing private practice cell therapy in Japan. Regen. Med. 2016;11:23–32. doi: 10.2217/rme.15.64. - DOI - PubMed
    1. Ikka T., Fujita M., Yashiro Y., Ikegaya H. Recent court ruling in Japan exemplifies another layer of regulation for regenerative therapy. Cell Stem Cell. 2015;17:507–508. doi: 10.1016/j.stem.2015.10.008. - DOI - PubMed
    1. Kashihara H., Nakayama T., Hatta T., Takahashi N., Fujita M. Evaluating the quality of website information of private-practice clinics offering cell therapies in Japan. Interact. J. Med. Res. 2016;5:e15. doi: 10.2196/ijmr.5479. - DOI - PMC - PubMed